158 related articles for article (PubMed ID: 31163124)
1. Effects of PPARs/20-HETE on the renal impairment under diabetic conditions.
Ding S; Huang J; Qiu H; Chen R; Zhang J; Huang B; Cheng O; Jiang Q
Exp Cell Res; 2019 Sep; 382(1):111455. PubMed ID: 31163124
[TBL] [Abstract][Full Text] [Related]
2. Activation of 20-HETE/PPARs involved in reno-therapeutic effect of naringenin on diabetic nephropathy.
Ding S; Qiu H; Huang J; Chen R; Zhang J; Huang B; Zou X; Cheng O; Jiang Q
Chem Biol Interact; 2019 Jul; 307():116-124. PubMed ID: 31063766
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological Blockade of PPAR Isoforms Increases Conditioned Fear Responding in the Presence of Nociceptive Tone.
Gaspar JC; Okine BN; Llorente-Berzal A; Roche M; Finn DP
Molecules; 2020 Feb; 25(4):. PubMed ID: 32102354
[TBL] [Abstract][Full Text] [Related]
4. Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats.
Ge J; Miao JJ; Sun XY; Yu JY
J Ethnopharmacol; 2016 Aug; 189():238-49. PubMed ID: 27224243
[TBL] [Abstract][Full Text] [Related]
5. Expression of cytochrome P-450 4 enzymes in the kidney and liver: regulation by PPAR and species-difference between rat and human.
Ito O; Nakamura Y; Tan L; Ishizuka T; Sasaki Y; Minami N; Kanazawa M; Ito S; Sasano H; Kohzuki M
Mol Cell Biochem; 2006 Mar; 284(1-2):141-8. PubMed ID: 16552476
[TBL] [Abstract][Full Text] [Related]
6. Role of 20-hydroxyeicosatetraenoic acid in altering vascular reactivity in diabetes.
Yousif MH; Benter IF; Dunn KM; Dahly-Vernon AJ; Akhtar S; Roman RJ
Auton Autacoid Pharmacol; 2009 Jan; 29(1-2):1-12. PubMed ID: 19302551
[TBL] [Abstract][Full Text] [Related]
7. 15-hydroxyeicosatetraenoic acid is a preferential peroxisome proliferator-activated receptor beta/delta agonist.
Naruhn S; Meissner W; Adhikary T; Kaddatz K; Klein T; Watzer B; Müller-Brüsselbach S; Müller R
Mol Pharmacol; 2010 Feb; 77(2):171-84. PubMed ID: 19903832
[TBL] [Abstract][Full Text] [Related]
8. Involvement of renal cytochromes P450 and arachidonic acid metabolites in diabetic nephropathy.
Eid S; Abou-Kheir W; Sabra R; Daoud G; Jaffa A; Ziyadeh FN; Roman L; Eid AA
J Biol Regul Homeost Agents; 2013; 27(3):693-703. PubMed ID: 24152838
[TBL] [Abstract][Full Text] [Related]
9. Glomerular 20-HETE, EETs, and TGF-beta1 in diabetic nephropathy.
Luo P; Zhou Y; Chang HH; Zhang J; Seki T; Wang CY; Inscho EW; Wang MH
Am J Physiol Renal Physiol; 2009 Mar; 296(3):F556-63. PubMed ID: 19129258
[TBL] [Abstract][Full Text] [Related]
10. Endoplasmic reticulum stress related factor IRE1α regulates TXNIP/NLRP3-mediated pyroptosis in diabetic nephropathy.
Ke R; Wang Y; Hong S; Xiao L
Exp Cell Res; 2020 Nov; 396(2):112293. PubMed ID: 32950473
[TBL] [Abstract][Full Text] [Related]
11. A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy.
Mou X; Zhou DY; Zhou D; Liu K; Chen LJ; Liu WH
Phytomedicine; 2020 Apr; 69():153192. PubMed ID: 32200292
[TBL] [Abstract][Full Text] [Related]
12. 20-Hydroxyeicosatetraenoic acid inhibits ATP-induced COX-2 expression via peroxisome proliferator activator receptor-α in vascular smooth muscle cells.
Liang CJ; Tseng CP; Yang CM; Ma YH
Br J Pharmacol; 2011 Jun; 163(4):815-25. PubMed ID: 21323895
[TBL] [Abstract][Full Text] [Related]
13. Activation of peroxisome proliferator-activated receptor-γ by a 12/15-lipoxygenase product of arachidonic acid: a possible neuroprotective effect in the brain after experimental intracerebral hemorrhage.
Xu R; Wang S; Li W; Liu Z; Tang J; Tang X
J Neurosurg; 2017 Sep; 127(3):522-531. PubMed ID: 27739938
[TBL] [Abstract][Full Text] [Related]
14. 20-HETE and EETs in diabetic nephropathy: a novel mechanistic pathway.
Eid S; Maalouf R; Jaffa AA; Nassif J; Hamdy A; Rashid A; Ziyadeh FN; Eid AA
PLoS One; 2013; 8(8):e70029. PubMed ID: 23936373
[TBL] [Abstract][Full Text] [Related]
15. EETs/PPARs activation together mediates the preventive effect of naringenin in high glucose-induced cardiomyocyte hypertrophy.
Zhang J; Qiu H; Huang J; Ding S; Huang B; Zhou P; Jiang Q
Biomed Pharmacother; 2019 Jan; 109():1498-1505. PubMed ID: 30551401
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice.
Cha DR; Zhang X; Zhang Y; Wu J; Su D; Han JY; Fang X; Yu B; Breyer MD; Guan Y
Diabetes; 2007 Aug; 56(8):2036-45. PubMed ID: 17536062
[TBL] [Abstract][Full Text] [Related]
17. Megalin/LRP2 expression is induced by peroxisome proliferator-activated receptor -alpha and -gamma: implications for PPARs' roles in renal function.
Cabezas F; Lagos J; Céspedes C; Vio CP; Bronfman M; Marzolo MP
PLoS One; 2011 Feb; 6(2):e16794. PubMed ID: 21311715
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of 20-hydroxyeicosatetraenoic acid (20-HETE) formation attenuate the natriuretic effect of dopamine.
Fernandez MM; Gonzalez D; Williams JM; Roman RJ; Nowicki S
Eur J Pharmacol; 2012 Jul; 686(1-3):97-103. PubMed ID: 22575524
[TBL] [Abstract][Full Text] [Related]
19. Activation of 20-HETE Synthase Triggers Oxidative Injury and Peripheral Nerve Damage in Type 2 Diabetic Mice.
Haddad M; Eid S; Harb F; Massry MEL; Azar S; Sauleau EA; Eid AA
J Pain; 2022 Aug; 23(8):1371-1388. PubMed ID: 35339661
[TBL] [Abstract][Full Text] [Related]
20. Colfibrate attenuates blood pressure and sodium retention in DOCA-salt hypertension.
Zhou Y; Luo P; Chang HH; Huang H; Yang T; Dong Z; Wang CY; Wang MH
Kidney Int; 2008 Oct; 74(8):1040-8. PubMed ID: 18596730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
